Professor Catherine Smith

Consultant Dermatologist, Honorary Professor of Dermatology and Therapeutics, St John’s Institute of Dermatology, Guy’s & St Thomas’ NHS Foundation Trust. Clinical lead of national specialised service in adult atopic eczema. Expertise in clinical and bioresource data collection (Lead for Guy’s and St Thomas’ NIHR BRC biobanking cutaneous medicine theme; BADBIR Co-Investigator since its inception (2007), Chair (2010-2015) and member of the Steering Committee). PI/Co-Investigator on trials investigating biologics and small molecules in atopic eczema.

Dr Louise Newell

Consultant Dermatologist, Bristol Royal Infirmary and Bristol Children’s Hospital. Extensive experience in managing severe eczema requiring systemic treatment, in adults and children. Leads dedicated severe eczema clinics for adults and children.

Dr Sara Brown

Professor of Molecular and Genetic Dermatology, Wellcome Trust Senior Research Fellow in Clinical Science, Honorary Consultant Dermatologist, Dundee; specialist clinics for adult and paediatric eczema; research expertise in genetic mechanisms in atopic skin; Steering Committee member of UK TREND (Translational Research Network in Dermatology) and co-lead of research investigating gene-environment interactions in atopic eczema pathogenesis.

Dr Richard Weller

Richard Weller, Reader and Honorary Consultant Dermatologist, University of Edinburgh. Runs the eczema clinic in NHS Lothian and is active in basic and clinical research in eczema. Dermatology Lead for NHS Research Scotland. Expert advisor to NICE on dermatology.

Dr Karolina Gholam

Being dually accredited in paediatrics and dermatology puts Dr Gholam in a unique position to look after children with complex skin disorders at Great Ormond Street Hospital. Her special interests are inflammatory dermatoses such as eczema and psoriasis, psychodermatology as well as laser and cutaneous surgery. She has a passion for teaching and lecture regularly on paediatric dermatology related topics to paediatricians and dermatologists in a variety of settings including national and international meetings. Her research interest is in inflammatory dermatoses and in particular psoriasis. She is the principal investigator in a prospective study on the use of Ustekinumab in children and has published in international journals in a variety of paediatric dermatology related topics.

Professor Nick Reynolds

Professor of Dermatology, Newcastle University, with a particular interest in therapeutics. Published one of the first stratified medicine studies in dermatology, a RCT of azathioprine in atopic eczema that utilised pharmacogenetic-based dosimetry. Co-Investigator in BADBIR since its inception, also leads one of the workstreams for PSORT. Director of Newcastle’s EPSRC/MRC Molecular Pathology Node, one of six units established in the UK to develop molecular diagnostic tools for stratification. Inaugural Chair UK TREND (Translational Research Network in Dermatology), now demitted and Past President of the European Society for Dermatological Research (ESDR).

Professor Alan Irvine

Professor in Dermatology, Trinity College Dublin and Consultant Dermatologist in Our Lady’s Children’s Hospital/St. James’s Hospital, Dublin, Ireland. His department in OLCHC manages or shares care for >95% of all Irish children on systemic therapy for atopic eczema. Alan has long standing interests in the mechanisms underlying AD and therapeutic approaches to this condition. Since 2013, Alan has led the development of skin registries for the Irish Skin Foundation.

Dr Graham Ogg

                
Professor of Dermatology, University of Oxford and Honorary Consultant Dermatologist, Oxford University Hospitals NHS Trust. Runs a specialist adult eczema clinic. Deputy Director of the MRC Human Immunology Unit and sub-theme lead for the Oxford NIHR Biomedical Research Centre, which supports basic science and clinic trial work. Longstanding interest in the immunology of atopic eczema, with a particular focus on the roles of innate lymphoid cells and lipid-specific CD1a-restricted T cells, and their impact on the epithelium.

Professor Christopher Griffiths

Foundation Professor of Dermatology, University of Manchester, and Honorary Consultant Dermatologist, Salford Royal NHS Foundation Trust, >30 years of research experience into inflammatory skin diseases with internationally recognised expertise in their management. Founder of the Dermatopharmacology Unit, University of Manchester. Involved in trials of all new biologics and small molecules in development for atopic eczema. Co-Founder and Chief Investigator of the British Association of Dermatologists Biologic Interventions Register (BADBIR) – gold standard web-based pharmacovigilance for psoriasis with 15,700 registrations.

Dr Paula Beattie

Dr Paula Beattie is a Consultant Dermatologist in Glasgow and Honorary Senior Lecturer at University of Glasgow. She has a clinical and research interest in Atopic Eczema in both Children and Adults and has been involved in a number of UK wide eczema studies and trials. She sat on the development committee for the NICE guideline for assessment and diagnosis of food allergy in children.

Professor Mike Cork

I joined the University of Sheffield in 1991 as a lecturer in dermatology whilst continuing as a practising dermatologist for the NHS in Sheffield. I had previously been a Registrar in Dermatology at the Royal Hallamshire Hospital, Sheffield, and before that a Registrar in Respiratory General Medicine at Leeds General Infirmary.

I have been closely involved with research in many areas of dermatology; including Atopic Eczema(dermatitis), Psoriasis, Vitiligo and the Genetics of Skin Disease. My major current research work is aimed at identifying gene–environment interactions in the development of atopic dermatitis leading to skin barrier breakdown and the understanding of how topical agents interact with the skin barrier; using this information to enhance the treatment of atopic dermatitis.

I am currently Head of Sheffield Dermatology Research in the Department of Infection, Immunity & Cardiovascular Disease at the University of Sheffield Medical School and am Honorary Consultant Dermatologist to both Sheffield Children´s Hospital NHS Foundation Trust and to Sheffield Teaching Hospitals NHS Foundation Trust; my time is evenly split between the University and the NHS.

Associate Professor Dr Michael R. Ardern-Jones BSc, MBBS, DPhil, FRCP

Michael Ardern-Jones (MAJ) trained in Dermatology at St John’s Institute of Dermatology, London and subsequently Oxford. His DPhil (PhD) at Oxford explored the immunology of atopic dermatitis. He was appointed to University Hospitals Southampton NHS Trust and to the Faculty of Medicine, University of Southampton in 2005.

He has a specific academic interest in inflammatory skin disease and leads the clinical service for eczema, skin allergy and drug hypersensitivity reactions. His clinical unit undertakes clinical trials in atopic eczema and other skin diseases. MAJ has long-standing research interest in all aspects of atopic eczema including: immunological mechanisms, immunotherapy, and the skin microbiome. His research lab comprises post-doctoral scientists, PhD students, clinical fellows and technicians.

Michael Ardern-Jones is President of the British Society for Medical Dermatology and Immediate Past Chair of the British Society for Investigative Dermatology. He also chairs The Skin Investigation Society. He is lead author on the Atopic eczema chapters and co-author for Drug allergy in Rook’s Textbook of Dermatology. He is an expert advisor to NICE and the MHRA on dermatology.

Dr John Ingram

Senior Lecturer and Consultant Dermatologist, Cardiff University and Cardiff & Vale University Health Board, with a particular interest in inflammatory skin disease. Editor-Elect of the British Journal of Dermatology and recipient of a five year Health Fellowship from Health and Care Research Wales (HCRW). Dermatology Specialty Lead for HCRW, coordinating dermatology clinical trials activity across Wales.